- Pulmatrix Inc PULM shares climbed 34.2 percent to $2.98 after surging 35.37 percent on Thursday.
- Stonegate Mortgage Corp SGM shares jumped 28.9 percent to $7.73. Home Point Financial agreed to acquire Stonegate Mortgage for $211 million.
- Lantronix Inc LTRX shares surged 17.9 percent to $1.91. Lantronix reported Q2 adjusted earnings of $0.03 per share on revenue of $11.2 million.
- K12 Inc. LRN gained 16.8 percent to $19.66. K12 reported Q2 earnings of $0.30 per share on revenue of $221.1 million.
- Technical Communications Corporation TCCO climbed 13.7 percent to $2.84. Technical Communications shares have declined 16.67 percent over the past 52 weeks, while the S&P 500 index has gained 21.97 percent in the same period.
- Globus Maritime Ltd GLBS shares rose 10.7 percent to $10.08. Globus Maritime shares have jumped 10,022.22 percent over the past 52 weeks, while the S&P 500 index has gained 21.97 percent in the same period.
- Celestica Inc CLS surged 9.5 percent to $13.97 after the company posted upbeat Q4 results.
- Centrue Financial Corp CFCB rose 9.3 percent to $25.11 after Midland States Bancorp Inc MSBI reported the purchase of Centrue Financial for estimated total consideration of $26.75 per share. Centrue Financial also reported Q4 earnings of $0.33 per share.
- Wynn Resorts, Limited WYNN shares climbed 8 percent to $103.12 after the company posted upbeat quarterly profit.
- Daqo New Energy Corp DQ surged 7.3 percent to $24.96. Craig-Hallum initiated coverage on Daqo New Energy with a Buy rating.
- VMware, Inc. VMW rose 6.2 percent to $89.42 after the company reported upbeat quarterly results and announced an additional buyback of $1.2 billion.
- Datawatch Corporation DWCH shares gained 6 percent to $7.05 after climbing 17.70 percent on Thursday.
- Bioverativ Inc BIVVV rose 4.6 percent to $45.76. Bioverativ will replace RH RH in the S&P MidCap 400, after the close of trading on February 2. Goldman Sachs initiated coverage on Bioverativ with a Buy rating.
- Neurocrine Biosciences, Inc. NBIX gained 3.3 percent to $41.09. Oppenheimer upgraded Neurocrine Biosciences from Perform to Outperform.
- Microsoft Corporation MSFT rose 2 percent to $65.54 as the company reported better-than-expected results for its fiscal second quarter on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: NewsIntraday UpdateMarketsAnalyst RatingsMoversBiotechnologyCommunications EquipmentConsumer DiscretionaryEducation ServicesHealth CareInformation TechnologyTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
